Related Experiment Video
Updated: Jun 3, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
The possible risk of cancer in claudicants
Bettina-Maria Taute1, Stephan Thommes, Ralf Taute
1Department of Internal Medicine III/Angiology, University Clinics of the Martin Luther-University of Halle-Wittenberg, Ernst-Grube-Strasse 40, Halle (Saale), Germany. bettina.taute@medizin.uni-halle.de
Insights
In patients with intermittent claudication, vascular and cancer-related deaths became equally significant over 10 years. Improved vascular care may shift mortality towards cancer, highlighting the need for comprehensive prevention strategies.
Area of Science:
- Vascular Medicine
- Oncology
- Public Health
Background:
- Peripheral artery disease, specifically intermittent claudication, necessitates long-term monitoring.
- Secondary prevention strategies aim to reduce vascular events in these patients.
- Understanding non-vascular comorbidities is crucial for comprehensive patient outcomes.
Purpose of the Study:
- To track vascular and non-vascular events in patients with intermittent claudication over a decade.
- To analyze causes of mortality in this cohort.
- To assess the impact of secondary prevention on patient outcomes.
Main Methods:
- Prospective 10-year follow-up of 109 patients with mild intermittent claudication.
- Recording of all vascular and non-vascular events.
- Analysis of mortality causes, including vascular events, cancer, and other factors.
Main Results:
- 534 events were recorded in 109 patients.
- Overall mortality was 25.7%, with 39% vascular and 36% cancer-related deaths.
- Smoking-related cancers occurred early (within 5 years), while severe vascular events appeared later.
- Mortality was equally attributed to vascular and cancer comorbidities.
Conclusions:
- Improvements in vascular care have shifted mortality patterns.
- Cancer incidence and mortality are becoming increasingly significant in claudicant populations.
- Integrated secondary prevention addressing both vascular and oncological risks is essential.
Abstract:
The aim of this study was to select a group of patients who had mild intermittent claudication and were undergoing secondary prevention measures, and record all vascular and non-vascular events over a 10-year follow-up. A total of 534 events were recorded in 109 claudicants. 25.7% of the claudicants died, 39% of them due to vascular events, 36% from cancer and 25% from other causes. 17 of the 20 cancer cases could be classified as related to smoking. Cancer occurred relatively early in the study, within the first five years, while severe vascular events occurred mainly during later periods. A clear transformation occurred in the outcome of the claudicants. Mortality was equally attributable to vascular and cancer-related comorbidities. In conclusion, the improvement of vascular outcomes due to secondary prevention measures and technological advances in the management of acute vascular events may result in a relative increase in cancer incidence and deaths.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
